Feature Channels:

Personalized Medicine

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Science

Channels:

Constant Challenge for Discovery Propels Harvinder Gill

The Texas Tech researcher has shown how vaccines can be administered more effectively through the use of creative methods of drug delivery.

Medicine

Channels:

Pancreatic Cancer, MD Anderson Cancer Center, personalized medicine

Scientists Identify Aggressive Pancreatic Cancer Cells and Their Vulnerability

A team from The University of Texas MD Anderson Cancer Center describes this week in the journal Nature a series of preclinical experiments using patient-derived tumor xenografts (PDXs) and mouse models that point to potential treatments for patients with a rapidly-progressing and resistant subgroup of tumor cells.

Medicine

Channels:

Every Diagnosis of Cancer Should Come with One of These, Says Cancer Expert

giordanoheadshot.png

“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.

Medicine

Channels:

drug, Aging, Cell Signaling, cell signaling pathways

UNM Cancer Center Researcher Discovers New Class of Drugs to Combat Aging Diseases

Eric Prossnitz, PhD and his team uncovered new details of the aging process. They discovered an altered balance between certain signaling molecules in the smooth muscle cells of blood vessels and the heart. The team also discovered a new class of drugs that combats an important part of the aging process.

Medicine

Channels:

Genetics, armc, Nature Communications, universite de montreal, mice study, Cushing's Syndrome

A New Immunologic and Endocrine Syndrome

2016_12_13_Wu_Jianping_0394m.jpg

After 10 years of research, a team at Université de Montréal's research centre has succeeded in deleting the Armc5 gene in experimental mice, discovering that its loss gives rise to a heretofore unidentified syndrome.

Medicine

Channels:

Fralin Life Science Institute, Virginia Tech Center for Drug Discovery, Malaria, malaria drug, Compound, Drug Resistance

Drug Discovery Researchers Awarded Grant to Refine Malaria Drug

VT122678_201619280116_lowres.jpg

A research team from the Virginia Tech Center for Drug Discovery has received a $431,126 two-year grant from the National Institutes of Health to make improved versions of a promising compound called MMV008138, or 8138 for short.

Medicine

Channels:

Chikungunya virus, Arthritis

Drug Combination Effective Against Chikungunya Arthritis in Mice

ArthriticHands.jpg

Chikungunya virus causes a painful, debilitating arthritis for which there is currently no treatment. A new study has found that combining a drug for rheumatoid arthritis with one that targets the chikungunya virus can eliminate the signs of arthritis in mice in the early stage of the disease.

Medicine

Channels:

Genetics, Height, Precision Medicine

Understanding the Genetics of Human Height

A large-scale international study involving more than 300 researchers, published today in Nature, heralds the discovery of 83 genetic variations controlling human height. To discover the 83 genetic variations, the research team measured the presence of 250,000 genetic variations in the study’s 700,000 participants – an enormous job. This study paves the way for precision medicine.

Medicine

Channels:

Cancer, Genetics, Drug Development

Potential New Drug Class Hits Multiple Cancer Cell Targets, Boosting Efficacy and Safety

In a new paper published this week in PNAS, researchers at the University of California San Diego School of Medicine and Moores Cancer Center, in collaboration with colleagues at Rady Children’s Hospital-San Diego, the University of Colorado School of Medicine and SignalRx, a San Diego-based biopharmaceutical company, describe a potential new class of anti-cancer drugs that inhibit two or more molecular targets at once, maximizing therapeutic efficiency and safety.

Science

Channels:

HIV, Hiv 1, Hiv Aids, HIV and AIDS, Hiv Treatment, HIV drug, Antiviral, Antiviral Drugs, Antiviral Therapeutics, Antiviral Therapies, antiviral therapy, antiretrovials, Antiretroviral, antiretroviral drug therapy, Antiretroviral Drug Treatment, Antiretroviral Drugs, Antiretroviral Regimen, antiretroviral therapies , Antiretroviral Therapy, antiretroviral the

UNMC Research Team Discovers Novel Pharmaceutic Action for HIV/AIDS

GendteamTeam.jpg

Using a process called LASER ART (long-acting slow effective release antiretroviral therapy), a research team has discovered an unexpected pathway to open cell storage areas for antiviral drugs. The discovery could revolutionize current treatments for HIV/AIDS by extending the actions of disease-combating medicines.







Chat now!